Non‐alcoholic fatty liver disease (NAFLD) is currently evolving as the most common liver
disease worldwide. It may progress to liver cirrhosis and liver cancer and is poised to …

Nonalcoholic fatty liver disease (NAFLD) is one of the causes of fatty liver, occurring when
fat is accumulated in the liver without alcohol consumption. NAFLD is the most common liver …

With the increased incidence of obesity, nonalcoholic fatty liver disease (NAFLD) has
become a major global health concern. The pathogenesis of NAFLD has not yet been fully …

The farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily that is
mainly expressed in liver, intestine, kidney and adipose tissue. On activation by bile acids …

Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent chronic liver condition
evolving in a proportion of patients into nonalcoholic steatohepatitis (NASH), an aggressive …

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic
syndrome and a risk factor for both cardiovascular and hepatic related morbidity and …

The prevalence of nonalcoholic fatty liver disease (NAFLD) worldwide has increased at an
alarming rate, which will likely result in enormous medical and economic burden. NAFLD …

Nonalcoholic steatohepatitis (NASH) is within the spectrum of nonalcoholic fatty liver
disease (NAFLD) and can progress to fibrosis, cirrhosis, and even hepatocellular carcinoma …

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic
syndrome and is one of the most prevalent liver disorders worldwide. NAFLD can gradually …

Non-alcoholic fatty liver disease (NAFLD) is characterized by the aberrant accumulation of
triglycerides in hepatocytes in the absence of significant alcohol consumption, viral infection …